Bipolar Disorder (Manic Depression) - Market Insight, Epidemiology and Market Forecast - 2028

Name: Bipolar Disorder (Manic Depression) - Market Insight, Epidemiology and Market Forecast - 2028
Brand: DelveInsight
SKU: B5C4E61C8B1EN
Price: 6250 USD
Availability: InStock

January 2019 | 100 pages | ID: B5C4E61C8B1EN
DelveInsight

US$ 6,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

This report can be delivered to the clients within 7-10 Business Days

DelveInsight's 'Bipolar Disorder (Manic Depression) - Market Insight, Epidemiology and Market Forecast - 2028' report provides a detailed analysis of the Bipolar Disorder (Manic Depression) epidemiology and market outlook for the 7MM.

MARKETS COVERED

United States
EU5 (Germany, France, Italy, Spain, and the United Kingdom)
Japan

Study Period: 2016-2028

Bipolar Disorder (Manic Depression) Understanding and Treatment Algorithm

The market report provides the overview of the Bipolar Disorder (Manic Depression) by providing the disease overview, definition, classification, symptoms, etiology, pathophysiology and diagnostic methods. It also covers the detailed treatment approaches and therapy areas under research and development for 7MM.
Bipolar Disorder (Manic Depression) Epidemiology

The report provides a comprehensive account of the total patient pool, diagnosed cases and potential patient pool eligible for the treatment. It also includes the explanation of changing trends of epidemiology after evaluating numerous studies, survey reports and views of key opinion leaders. The Report provides the 10 years forecast from 2016 to 2028 segmented by seven major markets, enabling to understand the potential of the Bipolar Disorder (Manic Depression) in the respective markets. The epidemiology data is presented with graphs and tables to provide a clear assessment of the landscape.
Bipolar Disorder (Manic Depression) Product Profiles & Analysis

The drug chapter segment covers the complete analysis of marketed drugs and Phase III & late Phase II pipeline drugs. This division focuses on the recent breakthroughs like clinical development analysis, agreements and collaborations, clinical trial details, allotted designations, published results, pharmacological effects, patent expiry, and expected launch timings. Moreover, advantages and disadvantages of the therapy along with opinion of experts for marketed and emerging drugs are also provided.
Bipolar Disorder (Manic Depression) Market Outlook

The report’s market outlook delivers an understanding of the country-specific revenue and share by analyzing the performance of the current therapies and potential uptake of new products. The in-depth analysis helps to recognize the growing demand of the market by evaluating the annual cost of therapy, compliance rate, competition with other therapies, covered patient segment, impact of emerging technology in the forecast period. The views from the key opinion leaders adds more value to the analysis. This segment provides the relevant graphs and tables to have an effective outline of the Bipolar Disorder (Manic Depression) market.
Bipolar Disorder (Manic Depression) Market Share by Therapies

This division provides an understanding of the rate of drug uptake, drugs including both recently launched and those which show potential to get launched during the forecast period from 2016-2028. The analysis is based on patient uptake by therapies, sales projection of each drug by studying the reasons behind the maximal use of new drugs. A comparative analysis is also done on the basis of market share and size by assessing the drugs uptake to project the drug positioning in the market.
Bipolar Disorder (Manic Depression) Report Insights

Patient Population in Bipolar Disorder (Manic Depression)
Therapeutic Approaches in Bipolar Disorder (Manic Depression)
Bipolar Disorder (Manic Depression) Pipeline Analysis
Bipolar Disorder (Manic Depression) Market Size and Trends
Bipolar Disorder (Manic Depression) Market Opportunities
Impact of upcoming Therapies in Bipolar Disorder (Manic Depression)

Bipolar Disorder (Manic Depression) Report Key Strengths

10 Year Forecast
7MM Coverage
Epidemiology Segmentation
Drugs Uptake
Highly Analyzed Market
Key Cross Competition

Bipolar Disorder (Manic Depression) Report Assessment

Current Treatment Practices in Bipolar Disorder (Manic Depression)
Unmet Needs in Bipolar Disorder (Manic Depression)
Market Attractiveness
Market Drivers and Barriers

KEY BENEFITS

The report will help to develop Business Strategies by understanding the trends shaping and driving the Bipolar Disorder (Manic Depression) market
Organize sales and marketing efforts by identifying the best opportunities for Bipolar Disorder (Manic Depression) market
To understand the future market competition in the Bipolar Disorder (Manic Depression) market.

1. REPORT INTRODUCTION

2. BIPOLAR DISORDER (MANIC DEPRESSION) MARKET OVERVIEW AT A GLANCE

2.1. Market Share Distribution of Bipolar Disorder (Manic Depression) in 2016
2.2. Market Share Distribution of Bipolar Disorder (Manic Depression) in 2028

3. DISEASE BACKGROUND AND OVERVIEW: BIPOLAR DISORDER (MANIC DEPRESSION)

3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment

4. EPIDEMIOLOGY AND PATIENT POPULATION

4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Bipolar Disorder (Manic Depression) in 7MM
4.3. Total Prevalent Patient Population of Bipolar Disorder (Manic Depression) in 7MM – By Countries

5. EPIDEMIOLOGY OF BIPOLAR DISORDER (MANIC DEPRESSION) BY COUNTRIES

5.1. United States
  5.1.1. Assumptions and Rationale
  5.1.2. Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression)
  5.1.3. Sub-Type Specific cases of the Bipolar Disorder (Manic Depression)
  5.1.4. Sex- Specific Cases of the Bipolar Disorder (Manic Depression)
  5.1.5. Diagnosed Cases of the Bipolar Disorder (Manic Depression)
  5.1.6. Treatable Cases of the Bipolar Disorder (Manic Depression)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
  5.4.1. Assumptions and Rationale
  5.4.2. Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression)
  5.4.3. Sub-Type Specific cases of the Bipolar Disorder (Manic Depression)
  5.4.4. Sex- Specific Cases of the Bipolar Disorder (Manic Depression)
  5.4.5. Diagnosed Cases of the Bipolar Disorder (Manic Depression)
  5.4.6. Treatable Cases of the Bipolar Disorder (Manic Depression)
5.5. France
  5.5.1. Assumptions and Rationale
  5.5.2. Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression)
  5.5.3. Sub-Type Specific cases of the Bipolar Disorder (Manic Depression)
  5.5.4. Sex- Specific Cases of the Bipolar Disorder (Manic Depression)
  5.5.5. Diagnosed Cases of the Bipolar Disorder (Manic Depression)
  5.5.6. Treatable Cases of the Bipolar Disorder (Manic Depression)
5.6. Italy
  5.6.1. Assumptions and Rationale
  5.6.2. Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression)
  5.6.3. Sub-Type Specific cases of the Bipolar Disorder (Manic Depression)
  5.6.4. Sex- Specific Cases of the Bipolar Disorder (Manic Depression)
  5.6.5. Diagnosed Cases of the Bipolar Disorder (Manic Depression)
  5.6.6. Treatable Cases of the Bipolar Disorder (Manic Depression)
5.7. Spain
  5.7.1. Assumptions and Rationale
  5.7.2. Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression)
  5.7.3. Sub-Type Specific cases of the Bipolar Disorder (Manic Depression)
  5.7.4. Sex- Specific Cases of the Bipolar Disorder (Manic Depression)
  5.7.5. Diagnosed Cases of the Bipolar Disorder (Manic Depression)
  5.7.6. Treatable Cases of the Bipolar Disorder (Manic Depression)
5.8. United Kingdom
  5.8.1. Assumptions and Rationale
  5.8.2. Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression)
  5.8.3. Sub-Type Specific cases of the Bipolar Disorder (Manic Depression)
  5.8.4. Sex- Specific Cases of the Bipolar Disorder (Manic Depression)
  5.8.5. Diagnosed Cases of the Bipolar Disorder (Manic Depression)
  5.8.6. Treatable Cases of the Bipolar Disorder (Manic Depression)
5.9. Japan
  5.9.1. Assumptions and Rationale
  5.9.2. Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression)
  5.9.3. Sub-Type Specific cases of the Bipolar Disorder (Manic Depression)
  5.9.4. Sex- Specific Cases of the Bipolar Disorder (Manic Depression)
  5.9.5. Diagnosed Cases of the Bipolar Disorder (Manic Depression)
  5.9.6. Treatable Cases of the Bipolar Disorder (Manic Depression)

6. CURRENT TREATMENT & MEDICAL PRACTICES

6.1. Treatment Algorithm
6.2. Treatment Guidelines

7. UNMET NEEDS OF THE BIPOLAR DISORDER (MANIC DEPRESSION)

8. MARKETED THERAPIES

8.1. Drug A: Company
  8.1.1. Drug Description
  8.1.2. Mechanism of Action
  8.1.3. Regulatory Milestones
  8.1.4. Advantages & Disadvantages
  8.1.5. Product Profile
8.2. Drug B: Company
  8.2.1. Drug Description
  8.2.2. Mechanism of Action
  8.2.3. Regulatory Milestones
  8.2.4. Advantages & Disadvantages
  8.2.5. Product Profile

9. PIPELINE THERAPIES – AT A GLANCE

10. KEY CROSS COMPETITION

11. EMERGING THERAPIES FOR BIPOLAR DISORDER (MANIC DEPRESSION)

11.1. Drug C: Company
  11.1.1. Drug Description
  11.1.2. Clinical Trials Details
  11.1.3. Safety and Efficacy Profile
  11.1.4. Advantages & Disadvantages
  11.1.5. Pipeline Development Activities
  11.1.6. Product Profile
11.2. Drug D: Company
  11.2.1. Drug Description
  11.2.2. Clinical Trials Details
  11.2.3. Safety and Efficacy Profile
  11.2.4. Advantages & Disadvantages
  11.2.5. Pipeline Development Activities
  11.2.6. Product Profile

12. BIPOLAR DISORDER (MANIC DEPRESSION): 7MM MARKET ANALYSIS

12.1. 7MM Market Size of Bipolar Disorder (Manic Depression)
12.2. 7MM Percentage Share of drugs marketed for Bipolar Disorder (Manic Depression)
12.3. 7MM Market Sales of Bipolar Disorder (Manic Depression) by Products

13. BIPOLAR DISORDER (MANIC DEPRESSION): COUNTRY-WISE MARKET ANALYSIS

13.1. United States
  13.1.1. Market Size of Bipolar Disorder (Manic Depression) in United States
  13.1.2. Percentage Share of drugs marketed for Bipolar Disorder (Manic Depression) in United States
  13.1.3. Market Sales of Bipolar Disorder (Manic Depression) by Products in United States
  13.1.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2. EU-5
  13.2.1. Germany
    13.2.1.1. Market Size of Bipolar Disorder (Manic Depression) in Germany
    13.2.1.2. Percentage Share of drugs marketed for Bipolar Disorder (Manic Depression) in Germany
    13.2.1.3. Market Sales of Bipolar Disorder (Manic Depression) by Products in Germany
    13.2.1.4. Analysis of Upcoming Therapies and their Impact on the Market
  13.2.2. France
    13.2.2.1. Market Size of Bipolar Disorder (Manic Depression) in France
    13.2.2.2. Percentage Share of drugs marketed for Bipolar Disorder (Manic Depression) in France
    13.2.2.3. Market Sales of Bipolar Disorder (Manic Depression) by Products in France
    13.2.2.4. Analysis of Upcoming Therapies and their Impact on the Market
  13.2.3. Italy
    13.2.3.1. Market Size of Bipolar Disorder (Manic Depression) in Italy
    13.2.3.2. Percentage Share of drugs marketed for Bipolar Disorder (Manic Depression) in Italy
    13.2.3.3. Market Sales of Bipolar Disorder (Manic Depression) by Products in Italy
    13.2.3.4. Analysis of Upcoming Therapies and their Impact on the Market
  13.2.4. Spain
    13.2.4.1. Market Size of Bipolar Disorder (Manic Depression) in Spain
    13.2.4.2. Percentage Share of drugs marketed for Bipolar Disorder (Manic Depression) in Spain
    13.2.4.3. Market Sales of Bipolar Disorder (Manic Depression) by Products in Spain
    13.2.4.4. Analysis of Upcoming Therapies and their Impact on the Market
  13.2.5. United Kingdom
    13.2.5.1. Market Size of Bipolar Disorder (Manic Depression) in United Kingdom
    13.2.5.2. Percentage Share of drugs marketed for Bipolar Disorder (Manic Depression) in United Kingdom
    13.2.5.3. Market Sales of Bipolar Disorder (Manic Depression) by Products in United Kingdom
    13.2.5.4. Analysis of Upcoming Therapies and their Impact on the Market
13.3. Japan
  13.3.1. Market Size of Bipolar Disorder (Manic Depression) in Japan
  13.3.2. Percentage Share of drugs marketed for Bipolar Disorder (Manic Depression) in Japan
  13.3.3. Market Sales of Bipolar Disorder (Manic Depression) by Products in Japan
  13.3.4. Analysis of Upcoming Therapies and their Impact on the Market

14. MARKET DRIVERS

15. MARKET BARRIERS

16. APPENDIX

17. REPORT METHODOLOGY

17.1. Sources

18. DELVEINSIGHT CAPABILITIES

19. DISCLAIMER

20. ABOUT DELVEINSIGHT

Indication Specific

LIST OF TABLES

Table 1: Total Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in 7MM
Table 2: Total Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in United States (2016-2028)
Table 5: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in United States (2016-2028)
Table 6: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in United States (2016-2028)
Table 7: Treatable Cases of the Bipolar Disorder (Manic Depression) in United States (2016-2028)
Table 8: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in Germany (2016-2028)
Table 9: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in Germany (2016-2028)
Table 10: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in Germany (2016-2028)
Table 11: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in Germany (2016-2028)
Table 12: Treatable Cases of the Bipolar Disorder (Manic Depression) in Germany (2016-2028)
Table 13: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in France (2016-2028)
Table 14: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in France (2016-2028)
Table 15: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in France (2016-2028)
Table 16: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in France (2016-2028)
Table 17: Treatable Cases of the Bipolar Disorder (Manic Depression) in France (2016-2028)
Table 18: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in Italy (2016-2028)
Table 19: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in Italy (2016-2028)
Table 20: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in Italy (2016-2028)
Table 21: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in Italy (2016-2028)
Table 22: Treatable Cases of the Bipolar Disorder (Manic Depression) in Italy (2016-2028)
Table 23: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in Spain (2016-2028)
Table 24: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in Spain (2016-2028)
Table 25: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in Spain (2016-2028)
Table 26: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in Spain (2016-2028)
Table 27: Treatable Cases of the Bipolar Disorder (Manic Depression) in Spain (2016-2028)
Table 28: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in UK (2016-2028)
Table 29: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in UK (2016-2028)
Table 30: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in UK (2016-2028)
Table 31: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in UK (2016-2028)
Table 32: Treatable Cases of the Bipolar Disorder (Manic Depression) in UK (2016-2028)
Table 33: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in Japan (2016-2028)
Table 34: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in Japan (2016-2028)
Table 35: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in Japan (2016-2028)
Table 36: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in Japan (2016-2028)
Table 37: Treatable Cases of the Bipolar Disorder (Manic Depression) in Japan (2016-2028)
Table 38: Marketed Therapies
Table 39: Emerging Therapies
Table 40: Key Cross Competition
Table 41:7MM- Market Size of Bipolar Disorder (Manic Depression) in USD MM (2016-2028)
Table 42:7MM- Market Share Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Table 43:7MM- Market Sales of Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Table 44: United States-Market Size of Bipolar Disorder (Manic Depression) in USD MM (2016-2028)
Table 45: United States-Market Share Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Table 46: United States-Market Sales of Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Table 47: Germany-Market Size of Bipolar Disorder (Manic Depression) in USD MM (2016-2028)
Table 48: Germany-Market Share Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Table 49: Germany-Market Sales of Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Table 50: France-Market Size of Bipolar Disorder (Manic Depression) in USD MM (2016-2028)
Table 51: France-Market Share Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Table 52: France-Market Sales of Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Table 53: Italy-Market Size of Bipolar Disorder (Manic Depression) in USD MM (2016-2028)
Table 54: Italy-Market Share Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Table 55: Italy-Market Sales of Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Table 56: Spain-Market Size of Bipolar Disorder (Manic Depression) in USD MM (2016-2028)
Table 57: Spain-Market Share Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Table 58: Spain-Market Sales of Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Table 59:UK-Market Size of Bipolar Disorder (Manic Depression) in USD MM (2016-2028)
Table 60:UK-Market Share Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Table 61:UK-Market Sales of Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Table 62: Japan-Market Size of Bipolar Disorder (Manic Depression) in USD MM (2016-2028)
Table 63: Japan-Market Share Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Table 64: Japan-Market Sales of Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)

LIST OF FIGURES

Figure 1: Total Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in United States (2016-2028)
Figure 5: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in United States (2016-2028)
Figure 6: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in United States (2016-2028)
Figure 7: Treatable Cases of the Bipolar Disorder (Manic Depression) in United States (2016-2028)
Figure 8: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in Germany (2016-2028)
Figure 9: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in Germany (2016-2028)
Figure 10: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in Germany (2016-2028)
Figure 11: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in Germany (2016-2028)
Figure 12: Treatable Cases of the Bipolar Disorder (Manic Depression) in Germany (2016-2028)
Figure 13: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in France (2016-2028)
Figure 14: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in France (2016-2028)
Figure 15: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in France (2016-2028)
Figure 16: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in France (2016-2028)
Figure 17: Treatable Cases of the Bipolar Disorder (Manic Depression) in France (2016-2028)
Figure 18: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in Italy (2016-2028)
Figure 19: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in Italy (2016-2028)
Figure 20: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in Italy (2016-2028)
Figure 21: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in Italy (2016-2028)
Figure 22: Treatable Cases of the Bipolar Disorder (Manic Depression) in Italy (2016-2028)
Figure 23: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in Spain (2016-2028)
Figure 24: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in Spain (2016-2028)
Figure 25: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in Spain (2016-2028)
Figure 26: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in Spain (2016-2028)
Figure 27: Treatable Cases of the Bipolar Disorder (Manic Depression) in Spain (2016-2028)
Figure 28: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in UK (2016-2028)
Figure 29: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in UK (2016-2028)
Figure 30: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in UK (2016-2028)
Figure 31: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in UK (2016-2028)
Figure 32: Treatable Cases of the Bipolar Disorder (Manic Depression) in UK (2016-2028)
Figure 33: Prevalent/Incident Cases of the Bipolar Disorder (Manic Depression) in Japan (2016-2028)
Figure 34: Sub-Type Specific cases of the Bipolar Disorder (Manic Depression) in Japan (2016-2028)
Figure 35: Sex- Specific Cases of the Bipolar Disorder (Manic Depression) in Japan (2016-2028)
Figure 36: Diagnosed Cases of the Bipolar Disorder (Manic Depression) in Japan (2016-2028)
Figure 37: Treatable Cases of the Bipolar Disorder (Manic Depression) in Japan (2016-2028)
Figure 38: Marketed Therapies
Figure 39: Emerging Therapies
Figure 40: Key Cross Competition
Figure 41:7MM- Market Size of Bipolar Disorder (Manic Depression) in USD MM (2016-2028)
Figure 42:7MM- Market Share Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Figure 43:7MM- Market Sales of Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Figure 44: United States-Market Size of Bipolar Disorder (Manic Depression) in USD MM (2016-2028)
Figure 45: United States-Market Share Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Figure 46: United States-Market Sales of Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Figure 47: Germany-Market Size of Bipolar Disorder (Manic Depression) in USD MM (2016-2028)
Figure 48: Germany-Market Share Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Figure 49: Germany-Market Sales of Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Figure 50: France-Market Size of Bipolar Disorder (Manic Depression) in USD MM (2016-2028)
Figure 51: France-Market Share Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Figure 52: France-Market Sales of Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Figure 53: Italy-Market Size of Bipolar Disorder (Manic Depression) in USD MM (2016-2028)
Figure 54: Italy-Market Share Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Figure 55: Italy-Market Sales of Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Figure 56: Spain-Market Size of Bipolar Disorder (Manic Depression) in USD MM (2016-2028)
Figure 57: Spain-Market Share Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Figure 58: Spain-Market Sales of Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Figure 59:UK-Market Size of Bipolar Disorder (Manic Depression) in USD MM (2016-2028)
Figure 60:UK-Market Share Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Figure 61:UK-Market Sales of Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Figure 62: Japan-Market Size of Bipolar Disorder (Manic Depression) in USD MM (2016-2028)
Figure 63: Japan-Market Share Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)
Figure 64: Japan-Market Sales of Bipolar Disorder (Manic Depression) by Therapies in USD MM (2016-2028)

Bipolar Disorder (Manic Depression) - Market Insight, Epidemiology and Market Forecast - 2028

More Publications

Need Help?

Ask a Question

Market Reports